vs
FirstCash Holdings, Inc.（FCFS）とPHIBRO ANIMAL HEALTH CORP（PAHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
FirstCash Holdings, Inc.の直近四半期売上が大きい（$501.3M vs $373.9M、PHIBRO ANIMAL HEALTH CORPの約1.3倍）。FirstCash Holdings, Inc.の純利益率が高く（20.8% vs 7.3%、差は13.4%）。FirstCash Holdings, Inc.の前年同期比売上増加率が高い（21.2% vs 20.9%）。過去8四半期でPHIBRO ANIMAL HEALTH CORPの売上複合成長率が高い（19.2% vs 16.9%）
FirstCash Holdings, Inc.は米国テキサス州フォートワースに本社を置く質屋事業を営む企業で、米国国内及びラテンアメリカ各地で小売型質店を展開しています。ナスダック証券取引所に上場しており、南北アメリカ全域に広範な事業基盤を有しています。
ファイブローアニマルヘルスコーポレーションは米国の動物健康・ミネラル栄養企業で、抗菌剤、抗コクシジウム剤、駆虫薬のほか、家畜用栄養補給剤、ワクチンなどを製品ラインナップに持っています。ミネラル栄養、機能材料、動物健康の3事業セグメントを中心に収益を上げ、米国、中南米、カナダ、欧州、中東、アフリカ、アジア太平洋地域で事業を展開しています。
FCFS vs PAHC — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $501.3M | $373.9M |
| 純利益 | $104.2M | $27.5M |
| 粗利率 | — | 35.5% |
| 営業利益率 | 28.5% | 13.5% |
| 純利益率 | 20.8% | 7.3% |
| 売上前年比 | 21.2% | 20.9% |
| 純利益前年比 | 24.7% | 762.1% |
| EPS（希薄化後） | $2.35 | $0.67 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $501.3M | $373.9M | ||
| Q3 25 | $411.0M | $363.9M | ||
| Q2 25 | $385.1M | $378.7M | ||
| Q1 25 | $371.1M | $347.8M | ||
| Q4 24 | $413.7M | $309.3M | ||
| Q3 24 | $363.1M | $260.4M | ||
| Q2 24 | $363.5M | $273.2M | ||
| Q1 24 | $366.8M | $263.2M |
| Q4 25 | $104.2M | $27.5M | ||
| Q3 25 | $82.8M | $26.5M | ||
| Q2 25 | $59.8M | $17.2M | ||
| Q1 25 | $83.6M | $20.9M | ||
| Q4 24 | $83.5M | $3.2M | ||
| Q3 24 | $64.8M | $7.0M | ||
| Q2 24 | $49.1M | $752.0K | ||
| Q1 24 | $61.4M | $8.4M |
| Q4 25 | — | 35.5% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 29.0% | ||
| Q1 25 | — | 30.1% | ||
| Q4 24 | — | 32.9% | ||
| Q3 24 | — | 32.1% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 30.2% |
| Q4 25 | 28.5% | 13.5% | ||
| Q3 25 | 27.4% | 14.1% | ||
| Q2 25 | 21.1% | 8.9% | ||
| Q1 25 | 30.0% | 9.6% | ||
| Q4 24 | 26.5% | 8.3% | ||
| Q3 24 | 23.5% | 6.8% | ||
| Q2 24 | 18.2% | 6.7% | ||
| Q1 24 | 22.3% | 7.6% |
| Q4 25 | 20.8% | 7.3% | ||
| Q3 25 | 20.1% | 7.3% | ||
| Q2 25 | 15.5% | 4.5% | ||
| Q1 25 | 22.5% | 6.0% | ||
| Q4 24 | 20.2% | 1.0% | ||
| Q3 24 | 17.9% | 2.7% | ||
| Q2 24 | 13.5% | 0.3% | ||
| Q1 24 | 16.7% | 3.2% |
| Q4 25 | $2.35 | $0.67 | ||
| Q3 25 | $1.86 | $0.65 | ||
| Q2 25 | $1.34 | $0.43 | ||
| Q1 25 | $1.87 | $0.51 | ||
| Q4 24 | $1.86 | $0.08 | ||
| Q3 24 | $1.44 | $0.17 | ||
| Q2 24 | $1.08 | $0.02 | ||
| Q1 24 | $1.35 | $0.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $125.2M | $74.5M |
| 総負債低いほど良い | $2.2B | $624.2M |
| 株主資本純資産 | $2.3B | $332.4M |
| 総資産 | $5.3B | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.98× | 1.88× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $125.2M | $74.5M | ||
| Q3 25 | $130.2M | $85.3M | ||
| Q2 25 | $101.5M | $77.0M | ||
| Q1 25 | $146.0M | $70.4M | ||
| Q4 24 | $175.1M | $67.1M | ||
| Q3 24 | $106.3M | $89.8M | ||
| Q2 24 | $113.7M | $114.6M | ||
| Q1 24 | $135.1M | $98.7M |
| Q4 25 | $2.2B | $624.2M | ||
| Q3 25 | $2.2B | $628.0M | ||
| Q2 25 | $1.7B | $631.7M | ||
| Q1 25 | $1.7B | $635.4M | ||
| Q4 24 | $1.7B | $639.1M | ||
| Q3 24 | $1.7B | $295.2M | ||
| Q2 24 | $1.7B | $312.1M | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $2.3B | $332.4M | ||
| Q3 25 | $2.2B | $311.7M | ||
| Q2 25 | $2.1B | $285.7M | ||
| Q1 25 | $2.1B | $266.0M | ||
| Q4 24 | $2.1B | $246.8M | ||
| Q3 24 | $2.0B | $258.5M | ||
| Q2 24 | $2.0B | $256.6M | ||
| Q1 24 | $2.0B | $270.1M |
| Q4 25 | $5.3B | $1.4B | ||
| Q3 25 | $5.2B | $1.4B | ||
| Q2 25 | $4.5B | $1.4B | ||
| Q1 25 | $4.4B | $1.3B | ||
| Q4 24 | $4.5B | $1.3B | ||
| Q3 24 | $4.4B | $966.3M | ||
| Q2 24 | $4.3B | $982.2M | ||
| Q1 24 | $4.2B | $979.0M |
| Q4 25 | 0.98× | 1.88× | ||
| Q3 25 | 1.01× | 2.01× | ||
| Q2 25 | 0.79× | 2.21× | ||
| Q1 25 | 0.83× | 2.39× | ||
| Q4 24 | 0.85× | 2.59× | ||
| Q3 24 | 0.87× | 1.14× | ||
| Q2 24 | 0.85× | 1.22× | ||
| Q1 24 | 0.75× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $206.6M | $19.4M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $8.3M |
| FCFマージンFCF / 売上 | — | 2.2% |
| 設備投資強度設備投資 / 売上 | — | 3.0% |
| キャッシュ転換率営業CF / 純利益 | 1.98× | 0.70× |
| 直近12ヶ月FCF直近4四半期 | — | $47.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $206.6M | $19.4M | ||
| Q3 25 | $135.8M | $9.3M | ||
| Q2 25 | $116.9M | $21.3M | ||
| Q1 25 | $126.6M | $43.2M | ||
| Q4 24 | $198.1M | $3.1M | ||
| Q3 24 | $113.1M | $12.6M | ||
| Q2 24 | $106.2M | $28.4M | ||
| Q1 24 | $122.5M | $11.4M |
| Q4 25 | — | $8.3M | ||
| Q3 25 | — | $-4.5M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | — | $35.4M | ||
| Q4 24 | — | $-4.7M | ||
| Q3 24 | — | $3.0M | ||
| Q2 24 | — | $15.4M | ||
| Q1 24 | — | $1.7M |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | -1.2% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 4.8% | ||
| Q1 24 | — | 3.7% |
| Q4 25 | 1.98× | 0.70× | ||
| Q3 25 | 1.64× | 0.35× | ||
| Q2 25 | 1.95× | 1.24× | ||
| Q1 25 | 1.51× | 2.07× | ||
| Q4 24 | 2.37× | 0.97× | ||
| Q3 24 | 1.74× | 1.81× | ||
| Q2 24 | 2.16× | 37.80× | ||
| Q1 24 | 2.00× | 1.36× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
PAHC
| Medicated Feed Additives And Others | $202.1M | 54% |
| Mineral Nutrition | $68.9M | 18% |
| Nutritional Specialties | $50.2M | 13% |
| Vaccines | $37.6M | 10% |
| Performance Products | $15.0M | 4% |
